Terms: = Bone cancer AND KLF6, RP11-184A2_1, 1316, ENSG00000067082, ST12, DKFZp686N0199, CPBP, Zf9, COPEB, ZF9, PAC1, GBF, BCD1 AND Clinical Outcome
740 results:
1. Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence.
Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
[TBL] [Abstract] [Full Text] [Related]
2. Tumours of the foot: A 10 years retrospective analysis.
Ajit Singh V; Sandhu V; Tze Yong C; Yasin NF
J Orthop Surg (Hong Kong); 2024; 32(1):10225536241248706. PubMed ID: 38662594
[TBL] [Abstract] [Full Text] [Related]
3. Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature.
Kritikos M; Vivanco-Suarez J; Teferi N; Lee S; Kato K; Eschbacher KL; Bathla G; Buatti JM; Hitchon PW
Neurosurg Rev; 2024 Feb; 47(1):75. PubMed ID: 38319484
[TBL] [Abstract] [Full Text] [Related]
4. Patient-Specific Measurable Residual Disease Markers Predict outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
Tobiasson M; Pandzic T; Illman J; Nilsson L; Weström S; Ejerblad E; Olesen G; Björklund A; Olsnes Kittang A; Werlenius O; Lorentz F; Rasmussen B; Cammenga J; Weber D; Lindholm C; Wiggh J; Dimitriou M; Moen AE; Yip Lundström L; von Bahr L; Baltzer-Sollander K; Jädersten M; Kytölä S; Walldin G; Ljungman P; Groenbaek K; Mielke S; Jacobsen SEW; Ebeling F; Cavelier L; Smidstrup Friis L; Dybedal I; Hellström-Lindberg E
J Clin Oncol; 2024 Apr; 42(12):1378-1390. PubMed ID: 38232336
[TBL] [Abstract] [Full Text] [Related]
5. Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort study.
Cargo C; Bernard E; Beinortas T; Bolton KL; Glover P; Warren H; Payne D; Ali R; Khan A; Short M; Van Hoppe S; Smith A; Taylor J; Evans P; Papaemmanuil E; Crouch S
Lancet Haematol; 2024 Jan; 11(1):e51-e61. PubMed ID: 38135373
[TBL] [Abstract] [Full Text] [Related]
6. clinical outcome in Patients With High-grade Soft-tissue Sarcoma Receiving Prosthetic Replacement After Tumor Resection of the Lower Extremities: Tokai Musculoskeletal Oncology Consortium Study.
Nakamura T; Sakai T; Tsukushi S; Kimura H; Wasa J; Hosono K; Izubuchi Y; Kozawa E; Nagano A; Asanuma K; Sudo A; Nishida Y
In Vivo; 2023; 37(6):2642-2647. PubMed ID: 37905645
[TBL] [Abstract] [Full Text] [Related]
7. Spinal intradural extramedullary tumors: microscopic keyhole resection with the focus on intraoperative neurophysiological monitoring and long-term outcome.
Yu B; Xiao Y; Dai H; Yu Y; Lin Y; Xu J
J Orthop Surg Res; 2023 Aug; 18(1):598. PubMed ID: 37574567
[TBL] [Abstract] [Full Text] [Related]
8. Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM.
Wong S; Hamidi H; Costa LJ; Bekri S; Neparidze N; Vij R; Nielsen TG; Raval A; Sareen R; Wassner-Fritsch E; Cho HJ
Front Immunol; 2023; 14():1085893. PubMed ID: 37559718
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of Baseline
Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
[TBL] [Abstract] [Full Text] [Related]
10. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
Tang Q; Lu J; Zhu X; Song G; Wu H; Xu H; Wang A; Wang J
Eur Spine J; 2023 Dec; 32(12):4297-4305. PubMed ID: 37318598
[TBL] [Abstract] [Full Text] [Related]
11. Comparative proteomic analysis of patients with acute myeloid leukemia before and after induction therapy.
Restrepo-Rodríguez L; Prada-Arismendy J; Castillo E; Rothlisberger S
Cancer Biomark; 2023; 37(4):227-235. PubMed ID: 37302023
[TBL] [Abstract] [Full Text] [Related]
12. [Percutaneous pedicle screw fixation combined expandable tubular retractor in the treatment of spinal metastases].
Cui YP; Shi XD; Liu J; Mi C; Wang B; Pan YX; Lin YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 55(3):530-536. PubMed ID: 37291930
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcomes of Intensity-modulated Carbon-ion Radiotherapy for bone and Soft Tissue Tumors.
Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
Anticancer Res; 2023 Jun; 43(6):2777-2781. PubMed ID: 37247930
[TBL] [Abstract] [Full Text] [Related]
14. Emergency Posterior Decompression for Metastatic Spine Tumors in Octogenarians: clinical Course and Prognostic Factors for Functional outcomes.
Lenga P; Gülec G; Bajwa AA; Issa M; Kiening K; Unterberg AW; Ishak B
World Neurosurg; 2023 Jul; 175():e1315-e1323. PubMed ID: 37164205
[TBL] [Abstract] [Full Text] [Related]
15. Genetic variants of CTLA4 are associated with clinical outcome of patients with multiple myeloma.
Gonzalez-Montes Y; Rodriguez-Romanos R; Villavicencio A; Osca-Gelis G; González-Bártulos M; Llopis F; Clapes V; Oriol A; Sureda A; Escoda L; Sarrà J; Garzó A; Lloveras N; Díez I; Granada I; Gallardo D
Front Immunol; 2023; 14():1158105. PubMed ID: 37122695
[TBL] [Abstract] [Full Text] [Related]
16. clinical implications of myeloid malignancy‑related somatic mutations in aplastic anemia.
Liu L; Zhang D; Fu Q; Wang J; Yu J; Chen D; Wang F; Guo R; Xie X; Jiang Z; Li Y
Clin Exp Med; 2023 Dec; 23(8):4473-4482. PubMed ID: 37087521
[TBL] [Abstract] [Full Text] [Related]
17. The clinicopathologic significance of NPM1 mutation and ability to detect mutated NPM1 by immunohistochemistry in non-AML myeloid neoplasms.
Kaseb H; Visconte V; Socha DS; Crane GM; Durkin L; Cook JR; Maciejewski JP; Hsi ED; Rogers HJ
Genes Chromosomes Cancer; 2023 Oct; 62(10):573-580. PubMed ID: 36959701
[TBL] [Abstract] [Full Text] [Related]
18. Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study.
Morimoto A; Shioda Y; Kudo K; Kanegane H; Imamura T; Koh K; Kosaka Y; Yuza Y; Nakazawa A; Saito AM; Watanabe T; Nakazawa Y
Int J Hematol; 2023 Jul; 118(1):107-118. PubMed ID: 36871086
[TBL] [Abstract] [Full Text] [Related]
19. Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL.
Thill M; Zahn MO; Welt A; Stickeler E; Nusch A; Fietz T; Rauh J; Wetzel N; Kruggel L; Jänicke M; Marschner N; Harbeck N; Wöckel A; Decker T;
Breast Cancer Res Treat; 2023 Apr; 198(3):545-553. PubMed ID: 36807725
[TBL] [Abstract] [Full Text] [Related]
20. Resistance to immune checkpoint inhibitors in advanced lung cancer: clinical characteristics, potential prognostic factors and next strategy.
Zhou J; Lu X; Zhu H; Ding N; Zhang Y; Xu X; Gao L; Zhou J; Song Y; Hu J
Front Immunol; 2023; 14():1089026. PubMed ID: 36776868
[TBL] [Abstract] [Full Text] [Related]
[Next]
